Global Liver Disease Treatment Market Anticipated to Garner $32,028.5 Million, Growing with 11.7% CAGR in the 2021–2028 Timeframe [240-Pages] | Wrap up by Research Dive
October 12, 2022 08:59 ET | Research Dive
New York, USA, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Research Dive has published a new report on the global liver disease treatment market. According to the report, the global market is projected to...
logo 600X600.png
Global Non-small Cell Lung Cancer Treatment Market to Surpass US$ 50,962.7 Million by 2030, Says Coherent Market Insights (CMI)
October 11, 2022 09:15 ET | CMI
Seattle, Oct. 11, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global non-small cell lung cancer treatment market is estimated to be valued at US$ 24,910.7 million in 2022 and...
Pet Cancer Therapeutics Market to hit USD 760 million by 2030, says Global Market Insights Inc.
August 16, 2022 03:15 ET | Global Market Insights Inc.
Selbyville, Delaware, Aug. 16, 2022 (GLOBE NEWSWIRE) -- The pet cancer therapeutics market value is anticipated to be valued over USD 760 million by 2030. Rising awareness pertaining to pet diseases...
Oncology Market Trends 2022 | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
May 12, 2022 08:00 ET | Graphical Research
Pune, India, May 12, 2022 (GLOBE NEWSWIRE) -- The global oncology market size is anticipated to rise substantially through 2028, attributed to the rising incidence of cancer across many regions...
Graphical Research.jpg
Breast Cancer Therapeutics Market Trends 2022 | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
March 02, 2022 06:00 ET | Graphical Research
Pune, India, March 02, 2022 (GLOBE NEWSWIRE) -- The global breast cancer therapeutics market size is estimated to grow at a significant CAGR during the forecast period, as prevalence of breast...
Curesponse Secures Additional USD 8 Million Funding for Its Breakthrough Precision Oncology Platform
November 15, 2021 14:35 ET | Curesponse
REẖOVOT, Israel, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Curesponse ( has secured additional USD 8 million funding for its breakthrough precision oncology platform. Curesponse is a...
Global Liver Disease Treatment Market Predicted to Generate a Revenue of $32,028.5 Million at a CAGR of 11.7% during the Forecast Period, 2021-2028 – Exclusive Report [240 Pages] By Research Dive
November 08, 2021 09:10 ET | Research Dive
New York, USA, Nov. 08, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global liver disease treatment market is predicted to garner $32,028.5 million at a CAGR of...
HUTCHMED and AstraZeneca Initiate SAMETA Global Phase III Trial of Savolitinib in Combination with PD-L1 Inhibitor IMFINZI® in Patients with MET-Driven Advanced Papillary Renal Cell Carcinoma
November 01, 2021 00:15 ET | HUTCHMED (China) Limited
— Follows multiple global studies of savolitinib in papillary renal cell carcinoma patients including SAVOIR and CALYPSO — — In CALYPSO, savolitinib and IMFINZI® combination demonstrated a 57%...
Logo V rgb original.jpg
BlossomHill Therapeutics Closes $71M Series A Financing
March 03, 2021 16:01 ET | BlossomHill Therapeutics, Inc.
SAN DIEGO, March 03, 2021 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc., a biopharmaceutical company focusing on oncology and autoimmune disorders, announced today that the company raised $71...
Reports and Data.jpeg-01
Acute Myeloid Leukemia Therapeutics Market To Reach USD 3.56 Billion By 2027 | Reports And Data
July 22, 2020 15:04 ET | Reports and Data
New York, July 22, 2020 (GLOBE NEWSWIRE) -- Market Size – USD 1.46 Billion in 2019, Market Growth - CAGR of 13.1%, Market Trends – Implementing various growth strategies in therapeutics. New York,...